HuGE Literature Finder
|
||
Records 1-100
|
Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
BMC cancer 2019 Apr 19 (1): 313. Shahi Rajendra Bahadur, De Brakeleer Sylvia, Caljon Ben, Pauwels Ingrid, Bonduelle Maryse, Joris Sofie, Fontaine Christel, Vanhoeij Marian, Van Dooren Sonia, Teugels Erik, De Grève Jacqu |
|
Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer.
International journal of cancer 2019 Jan 144 (2): 281-289. Li Jun-Yan, Jing Ruilin, Wei Hongyi, Wang Minghao, Xiaowei Qi, Liu Haoxi, Jian Liu, Ou Jiang-Hua, Jiang Wei-Hua, Tian Fu-Guo, Sheng Yuan, Li Heng-Yu, Xu Hong, Zhang Rui-Shan, Guan Ai-Hua, Liu Ke, Jiang Hong-Chuan, Ren Yu, He Jian-Jun, Huang Weiwei, Liao Ning, Cai Xiangjun, Ming Jia, Ling Rui, Xu Yan, Hu Chun-Yan, Zhang Jianguo, Guo Baoliang, Ouyang Lizhi, Shuai Ping, Liu Zhenzhen, Zhong Ling, Zeng Zhen, Zhang Ting, Xuan Zhaoling, Tan Xuanni, Liang Junbin, Pan Qinwen, Chen Li, Zhang Fan, Fan Lin-Jun, Zhang Yi, Yang Xinhua, BoLi Jing, Chen Chongjian, Jiang J |
|
Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer.
Endocrine 2018 Sep . Alzahrani Ali S, Murugan Avaniyapuram Kannan, Qasem Ebtesam, Alswailem Meshael M, AlGhamdi Balgees, Moria Yosra, Al-Hindi Hin |
|
Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
Breast cancer research : BCR 2018 Aug 20 (1): 87. Penkert Judith, Schmidt Gunnar, Hofmann Winfried, Schubert Stephanie, Schieck Maximilian, Auber Bernd, Ripperger Tim, Hackmann Karl, Sturm Marc, Prokisch Holger, Hille-Betz Ursula, Mark Dorothea, Illig Thomas, Schlegelberger Brigitte, Steinemann Dor |
|
Detection of novel germline mutations in six breast cancer predisposition genes by targeted next-generation sequencing.
Human mutation 2018 Jul . Dong Li, Wu Nan, Wang Shaojing, Cheng Yanan, Han Lei, Zhao Jing, Long Xinxin, Mu Kun, Li Menghui, Wei Lijuan, Wang Wanheng, Zhang Weijia, Cao Yandong, Liu Juntian, Yu Jinpu, Hao Xish |
|
Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer.
Genetics in medicine : official journal of the American College of Medical Genetics 2018 Jul . Yurgelun Matthew B, Chittenden Anu B, Morales-Oyarvide Vicente, Rubinson Douglas A, Dunne Richard F, Kozak Margaret M, Qian Zhi Rong, Welch Marisa W, Brais Lauren K, Da Silva Annacarolina, Bui Justin L, Yuan Chen, Li Tingting, Li Wanwan, Masuda Atsuhiro, Gu Mancang, Bullock Andrea J, Chang Daniel T, Clancy Thomas E, Linehan David C, Findeis-Hosey Jennifer J, Doyle Leona A, Thorner Aaron R, Ducar Matthew D, Wollison Bruce M, Khalaf Natalia, Perez Kimberly, Syngal Sapna, Aguirre Andrew J, Hahn William C, Meyerson Matthew L, Fuchs Charles S, Ogino Shuji, Hornick Jason L, Hezel Aram F, Koong Albert C, Nowak Jonathan A, Wolpin Brian |
|
Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Apr JCO2017773424. Reiner Anne S, Sisti Julia, John Esther M, Lynch Charles F, Brooks Jennifer D, Mellemkjær Lene, Boice John D, Knight Julia A, Concannon Patrick, Capanu Marinela, Tischkowitz Marc, Robson Mark, Liang Xiaolin, Woods Meghan, Conti David V, Duggan David, Shore Roy, Stram Daniel O, Thomas Duncan C, Malone Kathleen E, Bernstein Leslie, , Bernstein Jonine |
|
Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer.
PLoS genetics 2018 Apr 14 (4): e1007355. Paulo Paula, Maia Sofia, Pinto Carla, Pinto Pedro, Monteiro Augusta, Peixoto Ana, Teixeira Manuel |
|
A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer.
The Prostate 2018 Mar . Wu Yishuo, Yu Hongjie, Zheng S Lilly, Na Rong, Mamawala Mufaddal, Landis Tricia, Wiley Kathleen, Petkewicz Jacqueline, Shah Sameep, Shi Zhuqing, Novakovic Kristian, McGuire Michael, Brendler Charles B, Ding Qiang, Helfand Brian T, Carter H Ballentine, Cooney Kathleen A, Isaacs William B, Xu Jianfe |
|
CHEK2 Germ Line Mutations are Lacking among Familial and Sporadic Breast Cancer Patients in Rwanda
Asian Pacific journal of cancer prevention : APJCP 2018 Feb 19 (2): 375-379. Habyarimana Thierry, Attaleb Mohammed, Mugenzi Pacifique, Mazarati Jean Baptiste, Bakri Youssef, El Mzibri Mohamm |
|
Spectrum of APC and MUTYH germ-line mutations in Russian patients with colorectal malignancies.
Clinical genetics 2018 Feb . Yanus G A, Akhapkina T A, Ivantsov A O, Preobrazhenskaya E V, Aleksakhina S N, Bizin I V, Sokolenko A P, Mitiushkina N V, Kuligina E S, Suspitsin E N, Venina A R, Holmatov M M, Zaitseva O A, Yatsuk O S, Pashkov D V, Belyaev A M, Togo A V, Imyanitov E N, Iyevleva A |
|
Identification and analysis of CHEK2 germline mutations in Chinese BRCA1/2-negative breast cancer patients.
Breast cancer research and treatment 2018 Jan . Fan Zhenhua, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xu Ye, Xie Yunt |
|
Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication.
Clinical genetics 2018 03 93 (3): 595-602. Pelttari L M, Shimelis H, Toiminen H, Kvist A, Törngren T, Borg Å, Blomqvist C, Bützow R, Couch F, Aittomäki K, Nevanlinna |
|
Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk.
Genetics in medicine : official journal of the American College of Medical Genetics 2018 02 20 (2): 234-239. Caswell-Jin Jennifer L, Gupta Tanya, Hall Evan, Petrovchich Iva M, Mills Meredith A, Kingham Kerry E, Koff Rachel, Chun Nicolette M, Levonian Peter, Lebensohn Alexandra P, Ford James M, Kurian Allison |
|
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
JAMA oncology 2017 Sep 3 (9): 1190-1196. Couch Fergus J, Shimelis Hermela, Hu Chunling, Hart Steven N, Polley Eric C, Na Jie, Hallberg Emily, Moore Raymond, Thomas Abigail, Lilyquist Jenna, Feng Bingjian, McFarland Rachel, Pesaran Tina, Huether Robert, LaDuca Holly, Chao Elizabeth C, Goldgar David E, Dolinsky Jill |
|
CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population.
BMC cancer 2017 Sep 17 (1): 620. Hallamies Sanna, Pelttari Liisa M, Poikonen-Saksela Paula, Jekunen Antti, Jukkola-Vuorinen Arja, Auvinen Päivi, Blomqvist Carl, Aittomäki Kristiina, Mattson Johanna, Nevanlinna He |
Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry.
Journal of the National Cancer Institute 2017 Aug 109 (8): . Conti David V, Wang Kan, Sheng Xin, Bensen Jeannette T, Hazelett Dennis J, Cook Michael B, Ingles Sue A, Kittles Rick A, Strom Sara S, Rybicki Benjamin A, Nemesure Barbara, Isaacs William B, Stanford Janet L, Zheng Wei, Sanderson Maureen, John Esther M, Park Jong Y, Xu Jianfeng, Stevens Victoria L, Berndt Sonja I, Haiman Christopher A, |
|
Mutation Screening of 10 Cancer Susceptibility Genes in Unselected Breast Cancer Patients.
Clinical genetics 2017 Jun . Xie Yueliang, Guoli Li, Chen Ming, Guo Xinwu, Tang Lili, Luo Xipeng, Wang Shouman, Yi Wenjun, Dai Lizhong, Wang J |
|
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology 2017 May 28 (5): 1015-1022. Suenaga M, Schirripa M, Cao S, Zhang W, Yang D, Murgioni S, Rossini D, Marmorino F, Mennitto A, Ning Y, Okazaki S, Berger M D, Miyamoto Y, Gopez R, Barzi A, Yamaguchi T, Loupakis F, Lenz H |
|
Network Meta-Analysis on the Effects of DNA Damage Response-Related Gene Mutations on Overall Survival of Breast Cancer Based on TCGA Database.
Journal of cellular biochemistry 2017 May . Liu Chang, Chang Hong, Li Xiao-Han, Qi Ya-Fei, Wang Jin-Ou, Zhang Ying, Yang Xiang-Ho |
|
The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome.
Cancer research and treatment : official journal of Korean Cancer Association 2017 Apr 49 (2): 430-436. Lener Marcin R, Kashyap Aniruddh, Kluzniak Wojciech, Cybulski Cezary, Soluch Agnieszka, Pietrzak Sandra, Huzarski Tomasz, Gronwald Jacek, Lubinski J |
|
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology 2017 Feb . Suenaga M, Schirripa M, Cao S, Zhang W, Yang D, Murgioni S, Rossini D, Marmorino F, Mennitto A, Ning Y, Okazaki S, Berger M D, Miyamoto Y, Gopez R, Barzi A, Yamaguch T, Loupakis F, Lenz H |
|
High-risk epithelial ovarian cancer patients for hereditary ovarian cancer.
The journal of obstetrics and gynaecology research 2017 Feb . Chirasophon Seksit, Manchana Tarinee, Teerapakpinyo Chinacho |
|
Clinical Significance of DNA Damage Response Factors and Chromosomal Instability in Primary Lung Adenocarcinoma.
Anticancer research 2017 04 37 (4): 1729-1735. Okamoto Tatsuro, Kohno Mikihiro, Ito Kensaku, Takada Kazuki, Katsura Masakazu, Morodomi Yosuke, Toyokawa Gouji, Shoji Fumihiro, Maehara Yoshihi |
|
Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.
BMC medical genomics 2017 05 10 (1): 33. Cheng Donavan T, Prasad Meera, Chekaluk Yvonne, Benayed Ryma, Sadowska Justyna, Zehir Ahmet, Syed Aijazuddin, Wang Yan Elsa, Somar Joshua, Li Yirong, Yelskaya Zarina, Wong Donna, Robson Mark E, Offit Kenneth, Berger Michael F, Nafa Khedoudja, Ladanyi Marc, Zhang Liyi |
|
Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians.
Carcinogenesis 2017 05 38 (5): 511-518. Han Mi-Ryung, Zheng Wei, Cai Qiuyin, Gao Yu-Tang, Zheng Ying, Bolla Manjeet K, Michailidou Kyriaki, Dennis Joe, Wang Qin, Dunning Alison M, Brennan Paul, Chen Shou-Tung, Choi Ji-Yeob, Hartman Mikael, Ito Hidemi, Lophatananon Artitaya, Matsuo Keitaro, Miao Hui, Muir Kenneth, Sangrajrang Suleeporn, Shen Chen-Yang, Teo Soo Hwang, Tseng Chiu-Chen, Wu Anna H, Yip Cheng Har, Kang Daehee, Xiang Yong-Bing, Easton Douglas F, Shu Xiao-Ou, Long Jiro |
|
Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer.
Breast cancer research and treatment 2017 01 161 (1): 95-102. Kim Haeyoung, Cho Dae-Yeon, Choi Doo Ho, Oh Mijin, Shin Inkyung, Park Won, Huh Seung Jae, Nam Seok Jin, Lee Jeong Eon, Kim Seok W |
|
Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.
JAMA oncology 2017 12 3 (12): 1647-1653. Walsh Tom, Mandell Jessica B, Norquist Barbara M, Casadei Silvia, Gulsuner Suleyman, Lee Ming K, King Mary-Clai |
|
Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53.
International journal of cancer 2017 08 141 (4): 750-756. Lolas Hamameh Suhair, Renbaum Paul, Kamal Lara, Dweik Dima, Salahat Mohammad, Jaraysa Tamara, Abu Rayyan Amal, Casadei Silvia, Mandell Jessica B, Gulsuner Suleyman, Lee Ming K, Walsh Tom, King Mary-Claire, Levy-Lahad Ephrat, Kanaan Moe |
|
Germline Mutations in DNA Repair Genes in Lung Adenocarcinoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2017 11 12 (11): 1673-1678. Parry Erin M, Gable Dustin L, Stanley Susan E, Khalil Sara E, Antonescu Valentin, Florea Liliana, Armanios Ma |
|
Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing.
Cancer genetics 2017 01 210 22-27. Riahi Aouatef, Chabouni-Bouhamed Habiba, Kharrat Mah |
|
Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Nov 29 (11): 1381-1389. Ring Kari L, Bruegl Amanda S, Allen Brian A, Elkin Eric P, Singh Nanda, Hartman Anne-Renee, Daniels Molly S, Broaddus Russell |
|
Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.
Genetics in medicine : official journal of the American College of Medical Genetics 2016 Oct . Muranen Taru A, Greco Dario, Blomqvist Carl, Aittomäki Kristiina, Khan Sofia, Hogervorst Frans, Verhoef Senno, Pharoah Paul D P, Dunning Alison M, Shah Mitul, Luben Robert, Bojesen Stig E, Nordestgaard Børge G, Schoemaker Minouk, Swerdlow Anthony, García-Closas Montserrat, Figueroa Jonine, Dörk Thilo, Bogdanova Natalia V, Hall Per, Li Jingmei, Khusnutdinova Elza, Bermisheva Marina, Kristensen Vessela, Borresen-Dale Anne-Lise, Investigators Nbcs, Peto Julian, Dos Santos Silva Isabel, Couch Fergus J, Olson Janet E, Hillemans Peter, Park-Simon Tjoung-Won, Brauch Hiltrud, Hamann Ute, Burwinkel Barbara, Marme Frederik, Meindl Alfons, Schmutzler Rita K, Cox Angela, Cross Simon S, Sawyer Elinor J, Tomlinson Ian, Lambrechts Diether, Moisse Matthieu, Lindblom Annika, Margolin Sara, Hollestelle Antoinette, Martens John W M, Fasching Peter A, Beckmann Matthias W, Andrulis Irene L, Knight Julia A, Investigators kConFab/Aocs, Anton-Culver Hoda, Ziogas Argyrios, Giles Graham G, Milne Roger L, Brenner Hermann, Arndt Volker, Mannermaa Arto, Kosma Veli-Matti, Chang-Claude Jenny, Rudolph Anja, Devilee Peter, Seynaeve Caroline, Hopper John L, Southey Melissa C, John Esther M, Whittemore Alice S, Bolla Manjeet K, Wang Qin, Michailidou Kyriaki, Dennis Joe, Easton Douglas F, Schmidt Marjanka K, Nevanlinna He |
|
Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium.
Breast cancer research : BCR 2016 Oct 18 (1): 98. Muranen Taru A, Blomqvist Carl, Dörk Thilo, Jakubowska Anna, Heikkilä Päivi, Fagerholm Rainer, Greco Dario, Aittomäki Kristiina, Bojesen Stig E, Shah Mitul, Dunning Alison M, Rhenius Valerie, Hall Per, Czene Kamila, Brand Judith S, Darabi Hatef, Chang-Claude Jenny, Rudolph Anja, Nordestgaard Børge G, Couch Fergus J, Hart Steven N, Figueroa Jonine, García-Closas Montserrat, Fasching Peter A, Beckmann Matthias W, Li Jingmei, Liu Jianjun, Andrulis Irene L, Winqvist Robert, Pylkäs Katri, Mannermaa Arto, Kataja Vesa, Lindblom Annika, Margolin Sara, Lubinski Jan, Dubrowinskaja Natalia, Bolla Manjeet K, Dennis Joe, Michailidou Kyriaki, Wang Qin, Easton Douglas F, Pharoah Paul D P, Schmidt Marjanka K, Nevanlinna He |
|
Breast cancer risk is similar for CHEK2 founder and non-founder mutation carriers.
Cancer genetics 2016 Sep 209 (9): 403-407. Leedom Tracey P, LaDuca Holly, McFarland Rachel, Li Shuwei, Dolinsky Jill S, Chao Elizabeth |
|
Gene panel sequencing in familial Breast/Ovarian Cancer patients identifies multiple novel mutations also in genes others than BRCA1/2.
International journal of cancer 2016 Sep . Kraus Cornelia, Hoyer Juliane, Vasileiou Georgia, Wunderle Marius, Lux Michael P, Fasching Peter A, Krumbiegel Mandy, Uebe Steffen, Reuter Miriam, Beckmann Matthias W, Reis And |
|
Somatic mutation profiling of follicular thyroid cancer by next generation sequencing.
Molecular and cellular endocrinology 2016 Sep 433 130-7. Swierniak Michal, Pfeifer Aleksandra, Stokowy Tomasz, Rusinek Dagmara, Chekan Mykola, Lange Dariusz, Krajewska Jolanta, Oczko-Wojciechowska Ma?gorzata, Czarniecka Agnieszka, Jarzab Michal, Jarzab Barbara, Wojtas Barto |
|
Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH.
Breast cancer research and treatment 2016 Aug . Hackmann Karl, Kuhlee Franziska, Betcheva-Krajcir Elitza, Kahlert Anne-Karin, Mackenroth Luisa, Klink Barbara, Di Donato Nataliya, Tzschach Andreas, Kast Karin, Wimberger Pauline, Schrock Evelin, Rump Andre |
|
Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Jun . Schmidt Marjanka K, Hogervorst Frans, van Hien Richard, Cornelissen Sten, Broeks Annegien, Adank Muriel A, Meijers Hanne, Waisfisz Quinten, Hollestelle Antoinette, Schutte Mieke, van den Ouweland Ans, Hooning Maartje, Andrulis Irene L, Anton-Culver Hoda, Antonenkova Natalia N, Antoniou Antonis C, Arndt Volker, Bermisheva Marina, Bogdanova Natalia V, Bolla Manjeet K, Brauch Hiltrud, Brenner Hermann, Brüning Thomas, Burwinkel Barbara, Chang-Claude Jenny, Chenevix-Trench Georgia, Couch Fergus J, Cox Angela, Cross Simon S, Czene Kamila, Dunning Alison M, Fasching Peter A, Figueroa Jonine, Fletcher Olivia, Flyger Henrik, Galle Eva, García-Closas Montserrat, Giles Graham G, Haeberle Lothar, Hall Per, Hillemanns Peter, Hopper John L, Jakubowska Anna, John Esther M, Jones Michael, Khusnutdinova Elza, Knight Julia A, Kosma Veli-Matti, Kristensen Vessela, Lee Andrew, Lindblom Annika, Lubinski Jan, Mannermaa Arto, Margolin Sara, Meindl Alfons, Milne Roger L, Muranen Taru A, Newcomb Polly A, Offit Kenneth, Park-Simon Tjoung-Won, Peto Julian, Pharoah Paul D P, Robson Mark, Rudolph Anja, Sawyer Elinor J, Schmutzler Rita K, Seynaeve Caroline, Soens Julie, Southey Melissa C, Spurdle Amanda B, Surowy Harald, Swerdlow Anthony, Tollenaar Rob A E M, Tomlinson Ian, Trentham-Dietz Amy, Vachon Celine, Wang Qin, Whittemore Alice S, Ziogas Argyrios, van der Kolk Lizet, Nevanlinna Heli, Dörk Thilo, Bojesen Stig, Easton Douglas |
|
Germline variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms.
Blood 2016 Jun . Hinds David A, Barnholt Kimberly E, Mesa Ruben A, Kiefer Amy K, Do Chuong B, Eriksson Nicholas, Mountain Joanna L, Francke Uta, Tung Joyce Y, Nguyen Huong Marie, Zhang Haiyu, Gojenola Linda, Zehnder James L, Gotlib Jas |
|
Impact of SNPs on CpG Islands in the MYC and HRAS oncogenes and in a wide variety of tumor suppressor genes: a multi-cancer approach.
Cell cycle (Georgetown, Tex.) 2016 Apr 0. Samy Mohammad D, Yavorski John M, Mauro James A, Blanck Geor |
|
Do founder mutations characteristic of some cancer sites also predispose to pancreatic cancer?
International journal of cancer 2016 Mar . Lener Marcin R, Scott Rodney J, Klu?niak Wojciech, Baszuk Piotr, Cybulski Cezary, Wiechowska-Koz?owska Anna, Huzarski Tomasz, Byrski Tomasz, K?adny Józef, Pietrzak Sandra, Soluch Agnieszka, Jakubowska Anna, Lubi?ski J |
|
Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.
Oncotarget 2016 Mar . Lasorsa Vito Alessandro, Formicola Daniela, Pignataro Piero, Cimmino Flora, Calabrese Francesco Maria, Mora Jaume, Esposito Maria Rosaria, Pantile Marcella, Zanon Carlo, De Mariano Marilena, Longo Luca, Hogarty Michael D, de Torres Carmen, Tonini Gian Paolo, Iolascon Achille, Capasso Mar |
|
Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Mar . Tung Nadine, Lin Nancy U, Kidd John, Allen Brian A, Singh Nanda, Wenstrup Richard J, Hartman Anne-Renee, Winer Eric P, Garber Judy |
|
Increased Risk for Other Cancers in Addition to Breast Cancer for CHEK2*1100delC Heterozygotes Estimated From the Copenhagen General Population Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Feb . Näslund-Koch Charlotte, Nordestgaard Børge G, Bojesen Stig |
|
A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.
BMC medical genomics 2016 9 (1): 19. Mucaki Eliseos J, Caminsky Natasha G, Perri Ami M, Lu Ruipeng, Laederach Alain, Halvorsen Matthew, Knoll Joan H M, Rogan Peter |
|
Novel Nonsense Variants c.58C>T (p.Q20X) and c.256G>T (p.E85X) in the CHEK2 Gene Identified dentified in Breast Cancer Patients from Balochistan.
Asian Pacific journal of cancer prevention : APJCP 2016 17 (3): 1089-92. Baloch Abdul Hameed, Khosa Ahmad Nawaz, Bangulzai Nasrullah, Shuja Jamila, Naseeb Hafiz Khush, Jan Mohammad, Marghazani Illahi Bakhsh, Kakar Masood-Ul-Haq, Baloch Dost Mohammad, Cheema Abdul Majeed, Ahmad Jam |
|
Novel Nonsense Variants c.58C>T (p.Q20X) and c.256G>T (p.E85X) in the CHEK2 Gene Identified in Breast Cancer Patients from Balochistan.
Asian Pacific journal of cancer prevention : APJCP 2016 17 (7): 3623-6. Baloch Abdul Hameed, Khosa Ahmad Nawaz, Bangulzai Nasrullah, Shuja Jamila, Naseeb Hafiz Khush, Jan Mohammad, Marghazani Illahi Bakhsh, Kakar MasoodulHaq, Baloch Dost Mohammad, Cheema Abdul Majeed, Ahmad Jam |
|
Rare variants in BRCA2 and CHEK2 are associated with the risk of urinary tract cancers.
Scientific reports 2016 6 33542. Ge Yuqiu, Wang Yunyan, Shao Wei, Jin Jing, Du Mulong, Ma Gaoxiang, Chu Haiyan, Wang Meilin, Zhang Zhengdo |
|
Sensitivity of BRCA1/2 testing in high-risk breast/ovarian/male breast cancer families: little contribution of comprehensive RNA/NGS panel testing.
European journal of human genetics : EJHG 2016 11 24 (11): 1591-1597. Byers Helen, Wallis Yvonne, van Veen Elke M, Lalloo Fiona, Reay Kim, Smith Philip, Wallace Andrew J, Bowers Naomi, Newman William G, Evans D Gare |
|
Subtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysis.
JCI insight 2016 10 1 (16): e88755. Liu Wenjin, Snell Jeff M, Jeck William R, Hoadley Katherine A, Wilkerson Matthew D, Parker Joel S, Patel Nirali, Mlombe Yohannie B, Mulima Gift, Liomba N George, Wolf Lindsey L, Shores Carol G, Gopal Satish, Sharpless Norman |
|
Contribution of rare germline copy number variations and common susceptibility loci in Lynch Syndrome patients negative for mutations in the mismatch repair genes.
International journal of cancer. Journal international du cancer 2015 Dec . Villacis Rolando A R, Miranda Priscila M, Gomy Israel, Santos Erika M M, Carraro Dirce M, Achatz Maria I, Rossi Benedito M, Rogatto Silvia |
|
Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia.
Cancer 2015 Dec . Churpek Jane E, Marquez Rafael, Neistadt Barbara, Claussen Kimberly, Lee Ming K, Churpek Matthew M, Huo Dezheng, Weiner Howard, Bannerjee Mekhala, Godley Lucy A, Le Beau Michelle M, Pritchard Colin C, Walsh Tom, King Mary-Claire, Olopade Olufunmilayo I, Larson Richard |
|
Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.
Expert review of anticancer therapy 2015 Nov 1-12. Lerner-Ellis Jordan, Khalouei Sam, Sopik Victoria, Narod Steven |
|
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
The New England journal of medicine 2015 Oct 373 (18): 1697-708. Mateo Joaquin, Carreira Suzanne, Sandhu Shahneen, Miranda Susana, Mossop Helen, Perez-Lopez Raquel, Nava Rodrigues Daniel, Robinson Dan, Omlin Aurelius, Tunariu Nina, Boysen Gunther, Porta Nuria, Flohr Penny, Gillman Alexa, Figueiredo Ines, Paulding Claire, Seed George, Jain Suneil, Ralph Christy, Protheroe Andrew, Hussain Syed, Jones Robert, Elliott Tony, McGovern Ursula, Bianchini Diletta, Goodall Jane, Zafeiriou Zafeiris, Williamson Chris T, Ferraldeschi Roberta, Riisnaes Ruth, Ebbs Bernardette, Fowler Gemma, Roda Desamparados, Yuan Wei, Wu Yi-Mi, Cao Xuhong, Brough Rachel, Pemberton Helen, A'Hern Roger, Swain Amanda, Kunju Lakshmi P, Eeles Rosalind, Attard Gerhardt, Lord Christopher J, Ashworth Alan, Rubin Mark A, Knudsen Karen E, Feng Felix Y, Chinnaiyan Arul M, Hall Emma, de Bono Johann |
|
Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland.
Clinical genetics 2015 Oct 88 (4): 366-70. Cybulski C, Lubi?ski J, Woko?orczyk D, Ku?niak W, Kashyap A, Sopik V, Huzarski T, Gronwald J, Byrski T, Szwiec M, Jakubowska A, Górski B, D?bniak T, Narod S A, Akbari M |
|
Prevalence of pathogenic mutations in cancer predisposition genes among pancreatic cancer patients.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015 Oct . Hu Chunling, Hart Steven N, Bamlet William R, Moore Raymond M, Nandakumar Kannabiran, Eckloff Bruce W, Lee Yean K, Petersen Gloria M, McWilliams Robert R, Couch Fergus |
|
Rapid Detection Method for the Four Most Common CHEK2 Mutations Based on Melting Profile Analysis.
Molecular diagnosis & therapy 2015 Oct . Borun Pawel, Salanowski Kacper, Godlewski Dariusz, Walkowiak Jaroslaw, Plawski Andrz |
|
CHEK2 mutations and the risk of papillary thyroid cancer.
International journal of cancer. Journal international du cancer 2015 Aug 137 (3): 548-52. Sio?ek Monika, Cybulski Cezary, G?sior-Perczak Danuta, Kowalik Artur, Kozak-Klonowska Beata, Kowalska Aldona, Ch?opek Ma?gorzata, Klu?niak Wojciech, Woko?orczyk Dominika, Pa?yga Iwona, Walczyk Agnieszka, Lizis-Kolus Katarzyna, Sun Ping, Lubi?ski Jan, Narod Steven A, Gó?d? Stanis? |
|
Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer.
Genetics in medicine : official journal of the American College of Medical Genetics 2015 Aug 17 (8): 630-8. Maxwell Kara N, Wubbenhorst Bradley, D'Andrea Kurt, Garman Bradley, Long Jessica M, Powers Jacquelyn, Rathbun Katherine, Stopfer Jill E, Zhu Jiajun, Bradbury Angela R, Simon Michael S, DeMichele Angela, Domchek Susan M, Nathanson Katherine |
|
Candidate gene analysis of BRCA1/2 mutation-negative high-risk Russian breast cancer patients.
Cancer letters 2015 Apr 359 (2): 259-61. Sokolenko Anna P, Preobrazhenskaya Elena V, Aleksakhina Svetlana N, Iyevleva Aglaya G, Mitiushkina Natalia V, Zaitseva Olga A, Yatsuk Olga S, Tiurin Vladislav I, Strelkova Tatiana N, Togo Alexandr V, Imyanitov Evgeny |
|
CHEK2 c.1100delC allele is rarely identified in Greek breast cancer cases.
Cancer genetics 2015 Apr 208 (4): 129-34. Apostolou Paraskevi, Fostira Florentia, Papamentzelopoulou Myrto, Michelli Maria, Panopoulos Christos, Fountzilas George, Konstantopoulou Irene, Voutsinas Gerassimos E, Yannoukakos Drakoul |
|
A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk.
Oncogene 2015 Jan . Wang N, Ding H, Liu C, Li X, Wei L, Yu J, Liu M, Ying M, Gao W, Jiang H, Wang |
|
Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Cancer 2015 Jan 121 (1): 25-33. Tung Nadine, Battelli Chiara, Allen Brian, Kaldate Rajesh, Bhatnagar Satish, Bowles Karla, Timms Kirsten, Garber Judy E, Herold Christina, Ellisen Leif, Krejdovsky Jill, DeLeonardis Kim, Sedgwick Kristin, Soltis Kathleen, Roa Benjamin, Wenstrup Richard J, Hartman Anne-Ren |
|
Inherited predisposition to breast cancer among African American women.
Breast cancer research and treatment 2015 Jan 149 (1): 31-9. Churpek Jane E, Walsh Tom, Zheng Yonglan, Moton Zakiya, Thornton Anne M, Lee Ming K, Casadei Silvia, Watts Amanda, Neistadt Barbara, Churpek Matthew M, Huo Dezheng, Zvosec Cecilia, Liu Fang, Niu Qun, Marquez Rafael, Zhang Jing, Fackenthal James, King Mary-Claire, Olopade Olufunmilayo |
|
Association between CHEK2 H371Y mutation and response to neoadjuvant chemotherapy in women with breast cancer.
BMC cancer 2015 15 194. Liu Yin, Xu Ye, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xie Yunt |
|
Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma.
PloS one 2015 10 (10): e0140819. Havranek Ondrej, Kleiblova Petra, Hojny Jan, Lhota Filip, Soucek Pavel, Trneny Marek, Kleibl Zden |
|
Genomic profiling of CHEK2*1100delC-mutated breast carcinomas.
BMC cancer 2015 15 877. Massink Maarten P G, Kooi Irsan E, Martens John W M, Waisfisz Quinten, Meijers-Heijboer Han |
|
Impact of alcohol dehydrogenase gene 4 polymorphisms on esophageal squamous cell carcinoma risk in a Chinese population.
PloS one 2015 10 (6): e0127304. Xu Xiaoling, Wang Jiwen, Zhu Shuang-Mei, Yang Ming, Fang Yun, Zhao An, Song Qian, Mao Weim |
|
Low prevalence of CHEK2 gene mutations in multiethnic cohorts of breast cancer patients in Malaysia.
PloS one 2015 10 (1): e0117104. Mohamad Suriati, Isa Nurismah Md, Muhammad Rohaizak, Emran Nor Aina, Kitan Nor Mayah, Kang Peter, Kang In Nee, Taib Nur Aishah Mohd, Teo Soo Hwang, Akmal Sharifah No |
|
Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers.
PloS one 2015 10 (6): e0130393. Domagala Pawel, Jakubowska Anna, Jaworska-Bieniek Katarzyna, Kaczmarek Katarzyna, Durda Katarzyna, Kurlapska Agnieszka, Cybulski Cezary, Lubinski J |
|
Breast cancer sensitivity to neoadjuvant therapy in BRCA1 and CHEK2 mutation carriers and non-carriers.
Breast cancer research and treatment 2014 Dec 148 (3): 675-83. Pfeifer Werner, Sokolenko Anna P, Potapova Olga N, Bessonov Alexandr A, Ivantsov Alexandr O, Laptiev Sergey A, Zaitseva Olga A, Yatsuk Olga S, Matsko Dmitry E, Semiglazova Tatiana Yu, Togo Alexandr V, Imyanitov Evgeny |
|
Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.
European journal of human genetics : EJHG 2014 Nov 22 (11): 1305-13. Castéra Laurent, Krieger Sophie, Rousselin Antoine, Legros Angélina, Baumann Jean-Jacques, Bruet Olivia, Brault Baptiste, Fouillet Robin, Goardon Nicolas, Letac Olivier, Baert-Desurmont Stéphanie, Tinat Julie, Bera Odile, Dugast Catherine, Berthet Pascaline, Polycarpe Florence, Layet Valérie, Hardouin Agnes, Frébourg Thierry, Vaur Dominiq |
|
Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer.
Proceedings of the National Academy of Sciences of the United States of America 2014 Oct 111 (42): 15172-7. Kiiski Johanna I, Pelttari Liisa M, Khan Sofia, Freysteinsdottir Edda S, Reynisdottir Inga, Hart Steven N, Shimelis Hermela, Vilske Sara, Kallioniemi Anne, Schleutker Johanna, Leminen Arto, Bützow Ralf, Blomqvist Carl, Barkardottir Rosa B, Couch Fergus J, Aittomäki Kristiina, Nevanlinna He |
|
Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy.
British journal of cancer 2014 Aug 111 (5): 1004-13. Kriege M, Hollestelle A, Jager A, Huijts P E A, Berns E M, Sieuwerts A M, Meijer-van Gelder M E, Collée J M, Devilee P, Hooning M J, Martens J W M, Seynaeve |
|
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.
Nature genetics 2014 Jul 46 (7): 736-41. Wang Yufei, McKay James D, Rafnar Thorunn, Wang Zhaoming, Timofeeva Maria N, Broderick Peter, Zong Xuchen, Laplana Marina, Wei Yongyue, Han Younghun, Lloyd Amy, Delahaye-Sourdeix Manon, Chubb Daniel, Gaborieau Valerie, Wheeler William, Chatterjee Nilanjan, Thorleifsson Gudmar, Sulem Patrick, Liu Geoffrey, Kaaks Rudolf, Henrion Marc, Kinnersley Ben, Vallée Maxime, LeCalvez-Kelm Florence, Stevens Victoria L, Gapstur Susan M, Chen Wei V, Zaridze David, Szeszenia-Dabrowska Neonilia, Lissowska Jolanta, Rudnai Peter, Fabianova Eleonora, Mates Dana, Bencko Vladimir, Foretova Lenka, Janout Vladimir, Krokan Hans E, Gabrielsen Maiken Elvestad, Skorpen Frank, Vatten Lars, Njølstad Inger, Chen Chu, Goodman Gary, Benhamou Simone, Vooder Tonu, Välk Kristjan, Nelis Mari, Metspalu Andres, Lener Marcin, Lubi?ski Jan, Johansson Mattias, Vineis Paolo, Agudo Antonio, Clavel-Chapelon Francoise, Bueno-de-Mesquita H Bas, Trichopoulos Dimitrios, Khaw Kay-Tee, Johansson Mikael, Weiderpass Elisabete, Tjønneland Anne, Riboli Elio, Lathrop Mark, Scelo Ghislaine, Albanes Demetrius, Caporaso Neil E, Ye Yuanqing, Gu Jian, Wu Xifeng, Spitz Margaret R, Dienemann Hendrik, Rosenberger Albert, Su Li, Matakidou Athena, Eisen Timothy, Stefansson Kari, Risch Angela, Chanock Stephen J, Christiani David C, Hung Rayjean J, Brennan Paul, Landi Maria Teresa, Houlston Richard S, Amos Christopher |
|
Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.
Breast cancer research and treatment 2014 Jun 145 (2): 553-62. Sokolenko Anna P, Bogdanova Natalia, Kluzniak Wojciech, Preobrazhenskaya Elena V, Kuligina Ekatherina S, Iyevleva Aglaya G, Aleksakhina Svetlana N, Mitiushkina Natalia V, Gorodnova Tatiana V, Bessonov Alexandr A, Togo Alexandr V, Lubi?ski Jan, Cybulski Cezary, Jakubowska Anna, Dörk Thilo, Imyanitov Evgeny |
|
Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma.
Genes, chromosomes & cancer 2014 Jun 53 (6): 516-23. Wójcicka Anna, Czetwerty?ska Ma?gorzata, ?wierniak Micha?, D?ugosi?ska Joanna, Maci?g Monika, Czajka Agnieszka, Dymecka Kinga, Kubiak Anna, Kot Adam, P?oski Rafa?, de la Chapelle Albert, Ja?d?ewski Krysti |
|
Genetic association of CHEK2, GSTP1, and ERCC1 with glioblastoma in the Han Chinese population.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 May 35 (5): 4937-41. Dong Yu-Shu, Hou Wu-Gang, Li Xiao-Lan, Jin Tian-Bo, Li Yue, Feng Da-Yun, Liu De-Bao, Gao Guo-Dong, Yin Zhong-Min, Qin Huai-Zh |
|
Survival from breast cancer in patients with CHEK2 mutations.
Breast cancer research and treatment 2014 Apr 144 (2): 397-403. Huzarski T, Cybulski C, Wokolorczyk D, Jakubowska A, Byrski T, Gronwald J, Domaga?a P, Szwiec M, Godlewski D, Kilar E, Marczyk E, Sio?ek M, Wi?niowski R, Janiszewska H, Surdyka D, Sibilski R, Sun P, Lubi?ski J, Narod S |
|
Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence.
Gut 2014 Feb 63 (2): 326-36. Ma Xiangyu, Zhang Ben, Zheng W |
|
Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Feb 20 (3): 764-75. Pennington Kathryn P, Walsh Tom, Harrell Maria I, Lee Ming K, Pennil Christopher C, Rendi Mara H, Thornton Anne, Norquist Barbara M, Casadei Silvia, Nord Alexander S, Agnew Kathy J, Pritchard Colin C, Scroggins Sheena, Garcia Rochelle L, King Mary-Claire, Swisher Elizabeth |
|
CHEK2*1100delC homozygosity in the Netherlands--prevalence and risk of breast and lung cancer.
European journal of human genetics : EJHG 2014 Jan 22 (1): 46-51. Huijts Petra E A, Hollestelle Antoinette, Balliu Brunilda, Houwing-Duistermaat Jeanine J, Meijers Caro M, Blom Jannet C, Ozturk Bahar, Krol-Warmerdam Elly M M, Wijnen Juul, Berns Els M J J, Martens John W M, Seynaeve Caroline, Kiemeney Lambertus A, van der Heijden Henricus F, Tollenaar Rob A E M, Devilee Peter, van Asperen Christi |
|
Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germ-line mutation and non-CHEK2 somatic mutation gene signatures.
Cell cycle (Georgetown, Tex.) 2014 13 (14): 2262-80. Ow Ghim Siong, Ivshina Anna V, Fuentes Gloria, Kuznetsov Vladimir |
|
Lack of CHEK2 gene mutations in differentiated thyroid carcinoma patients using high resolution melting analysis.
Asian Pacific journal of cancer prevention : APJCP 2014 15 (12): 5019-22. Fayaz Shima, Fard-Esfahani Pezhman, Torbati Peyman Mohamma |
|
Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.
Breast cancer research : BCR 2014 16 (3): R58. Damiola Francesca, Pertesi Maroulio, Oliver Javier, Le Calvez-Kelm Florence, Voegele Catherine, Young Erin L, Robinot Nivonirina, Forey Nathalie, Durand Geoffroy, Vallée Maxime P, Tao Kayoko, Roane Terrell C, Williams Gareth J, Hopper John L, Southey Melissa C, Andrulis Irene L, John Esther M, Goldgar David E, Lesueur Fabienne, Tavtigian Sean |
|
Genetic variants in DNA repair pathway genes and risk of esophageal squamous cell carcinoma and gastric adenocarcinoma in a Chinese population.
Carcinogenesis 2013 Jul 34 (7): 1536-42. Li Wen-Qing, Hu Nan, Hyland Paula L, Gao Ying, Wang Zhao-Ming, Yu Kai, Su Hua, Wang Chao-Yu, Wang Le-Min, Chanock Stephen J, Burdett Laurie, Ding Ti, Qiao You-Lin, Fan Jin-Hu, Wang Yuan, Xu Yi, Shi Jian-Xin, Gu Fangyi, Wheeler William, Xiong Xiao-Qin, Giffen Carol, Tucker Margaret A, Dawsey Sanford M, Freedman Neal D, Abnet Christian C, Goldstein Alisa M, Taylor Philip |
|
A personalised approach to prostate cancer screening based on genotyping of risk founder alleles.
British journal of cancer 2013 Jun 108 (12): 2601-9. Cybulski C, Woko?orczyk D, Klu?niak W, Kashyap A, Go??b A, S?ojewski M, Sikorski A, Puszy?ski M, Soczawa M, Borkowski T, Borkowski A, Antczak A, Przyby?a J, Sosnowski M, Ma?kiewicz B, Zdrojowy R, Domaga?a P, Piotrowski K, Menkiszak J, Krzystolik K, Gronwald J, Jakubowska A, Górski B, D?bniak T, Masoj? B, Huzarski T, Muir K R, Lophatananon A, Lubi?ski J, Narod S A, |
|
Haplotype analysis of eight genes of the monoubiquitinated FANCD2-DNA damage-repair pathway in breast cancer patients.
Cancer epidemiology 2013 Jun 37 (3): 311-7. Tang Li-Li, Chen Fei-Yu, Wang Hao, Hu Xue-Li, Dai Xu, Mao Jie, Shen Zheng-Tang, Wu Yu-Hui, Wang Shou-Man, Hai Jian, Yan Guo-Jiao, Li Hui, Huang Ju |
|
The effect of CHEK2 variant I157T on cancer susceptibility: evidence from a meta-analysis.
DNA and cell biology 2013 Jun 32 (6): 329-35. Han Fei-fei, Guo Chang-long, Liu Li-ho |
|
Excess breast cancer risk in first degree relatives of CHEK2?1100delC positive familial breast cancer cases.
European journal of cancer (Oxford, England : 1990) 2013 May 49 (8): 1993-9. Adank Muriel A, Verhoef Senno, Oldenburg Rogier A, Schmidt Marjanka K, Hooning Maartje J, Martens John W M, Broeks Annegien, Rookus Matti, Waisfisz Quinten, Witte Birgit I, Jonker Marianne A, Meijers-Heijboer Han |
|
BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma.
Cancer 2013 Jan 119 (2): 332-8. Pennington Kathryn P, Walsh Tom, Lee Ming, Pennil Christopher, Novetsky Akiva P, Agnew Kathy J, Thornton Anne, Garcia Rochelle, Mutch David, King Mary-Claire, Goodfellow Paul, Swisher Elizabeth |
|
CHK2 1100delC, IVS2+1G>A and I157T mutations are not present in hepatocellular cancer cases from a Turkish population.
Gene 2013 Jan 512 (2): 232-6. Bayram Süleyman, Akk?z Hikmet, Topakta? Mehm |
|
The risk of gastric cancer in carriers of CHEK2 mutations.
Familial cancer 2013 Jan . Teodorczyk U, Cybulski C, Woko?orczyk D, Jakubowska A, Starzy?ska T, Lawniczak M, Domaga?a P, Ferenc K, Marlicz K, Banaszkiewicz Z, Wi?niowski R, Narod SA, Lubi?ski J |
|
Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan.
BMC cancer 2013 13 312. Rashid Muhammad U, Muhammad Noor, Faisal Saima, Amin Asim, Hamann U |
|
Identification of a novel BRCA2 and CHEK2 A-C-G-C haplotype in Turkish patients affected with breast cancer.
Asian Pacific journal of cancer prevention : APJCP 2013 14 (5): 3229-35. Haytural Hazal, Yalcinkaya Nazli, Akan Gokce, Arikan Soykan, Ozkok Elif, Cakmakoglu Bedia, Yaylim Ilhan, Aydin Makbule, Atalar Fatmah |
|
CHEK2 1100DELC germline mutation: a frequency study in hereditary breast and colon cancer Brazilian families.
Arquivos de gastroenterologia 2012 Dec 49 (4): 273-8. Abud Jamile, Prolla João Carlos, |
|
CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Dec 30 (35): 4308-16. Weischer Maren, Nordestgaard Børge G, Pharoah Paul, Bolla Manjeet K, Nevanlinna Heli, Van't Veer Laura J, Garcia-Closas Montserrat, Hopper John L, Hall Per, Andrulis Irene L, Devilee Peter, Fasching Peter A, Anton-Culver Hoda, Lambrechts Diether, Hooning Maartje, Cox Angela, Giles Graham G, Burwinkel Barbara, Lindblom Annika, Couch Fergus J, Mannermaa Arto, Grenaker Alnæs Grethe, John Esther M, Dörk Thilo, Flyger Henrik, Dunning Alison M, Wang Qin, Muranen Taru A, van Hien Richard, Figueroa Jonine, Southey Melissa C, Czene Kamila, Knight Julia A, Tollenaar Rob A E M, Beckmann Matthias W, Ziogas Argyrios, Christiaens Marie-Rose, Collée Johanna Margriet, Reed Malcolm W R, Severi Gianluca, Marme Frederik, Margolin Sara, Olson Janet E, Kosma Veli-Matti, Kristensen Vessela N, Miron Alexander, Bogdanova Natalia, Shah Mitul, Blomqvist Carl, Broeks Annegien, Sherman Mark, Phillips Kelly-Anne, Li Jingmei, Liu Jianjun, Glendon Gord, Seynaeve Caroline, Ekici Arif B, Leunen Karin, Kriege Mieke, Cross Simon S, Baglietto Laura, Sohn Christof, Wang Xianshu, Kataja Vesa, Børresen-Dale Anne-Lise, Meyer Andreas, Easton Douglas F, Schmidt Marjanka K, Bojesen Stig |
|
Identification of a novel in-frame deletion in BRCA2 and analysis of variants of BRCA1/2 in Italian patients affected with hereditary breast and ovarian cancer.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2012 Dec 50 (12): 2171-80. Vietri Maria Teresa, Molinari Anna Maria, Laura De Paola Maria, Cantile Flavia, Fasano Morena, Cioffi Miche |
|
An inherited NBN mutation is associated with poor prognosis prostate cancer.
British journal of cancer 2012 Nov . Cybulski C, Woko?orczyk D, Klu?niak W, Jakubowska A, Górski B, Gronwald J, Huzarski T, Kashyap A, Byrski T, D?bniak T, Go??b A, Gliniewicz B, Sikorski A, Swita?a J, Borkowski T, Borkowski A, Antczak A, Wojnar L, Przyby?a J, Sosnowski M, Ma?kiewicz B, Zdrojowy R, Sikorska-Radek P, Matych J, Wilkosz J, Ró?a?ski W, Ki? J, Bar K, Bryniarski P, Paradysz A, Jersak K, Niemirowicz J, S?upski P, Jarzemski P, Skrzypczyk M, Dobruch J, Domaga?a P, Narod SA, Lubi?ski J |
- Page last reviewed:Jul 30, 2019
- Page last updated:Nov 14, 2019
- Content source: